Showing posts with label
Vanguard
.
Show all posts
Showing posts with label
Vanguard
.
Show all posts
Wednesday, July 23, 2025
Why do Nvidia and so many institutional investors own most of the shares of RXRX - Recursion Pharma
›
Why Nvidia Invested in RXRX 1. Deep AI Integration for Drug Discovery In July 2023, Nvidia invested $50 million via a PIPE deal to he...
Friday, June 27, 2025
When the tech "hits the fan" so to speak, who might bid for Cabaletta Bio and their cutting edge technology?
›
Cabaletta Bio is a compelling acquisition target in a growing niche— cell therapy for autoimmune diseases . Its unique platform, strong e...
Tuesday, May 27, 2025
Cabaletta Bio (CABA) is a microcap stock with a serious pipeline in the Healthcare field, and a possible takeover target. Read on...
›
Cabaletta Bio Might See a Takeover Offer in the Near Future Date: May 27, 2025 Ticker: NASDAQ: CABA Sector: Biotechnology Market Ca...
Friday, March 7, 2025
What's up with UiPath, it's Robotics Automation and it's recent push into healthcare?
›
Below is a comprehensive investment and business report on UiPath N Y S E : P A T H Please note that all figures and information are b...
›
Home
View web version
